By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Radius Health 

950 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-551-4000 Fax: 617-551-4701


SEARCH JOBS

Radius is a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases.

Radius is committed to the research and development of new therapeutics for the large and underserved osteoporosis market.


YEAR FOUNDED:

October 3, 2003

LEADERSHIP:

Founders: John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt and John T. Potts

CEO: Robert Ward

CMO (Medical): Lorraine Fitzpatrick

CFO: Nick Harvey

CSO (Scientific): Gary Hattersley

JOBS:

Please click here for Radius Health job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@radiuspharm.com
Ownership: Public

Web Site: Radius Health
Employees:
Symbol: RDUS
 



Industry
Pharmaceutical






Company News
Radius Health (RDUS) Announces Pricing Of $300 Million Of 3.00% Convertible Senior Notes Due 2024 8/9/2017 11:03:49 AM
Radius Health (RDUS) Announces Proposed Public Offering Of $300 Million Of Convertible Senior Notes Due 2024 8/8/2017 8:50:58 AM
Radius Health (RDUS) Reports Second Quarter 2017 Financial And Operating Results And Provides Business Update 8/4/2017 11:50:18 AM
Radius Health (RDUS) Announces New Employment Inducement Grant 7/18/2017 10:45:25 AM
Radius Health (RDUS)'s Longtime CEO Out, Former Novo Nordisk A/S (NVO) Exec Named New Leader 7/17/2017 5:40:02 AM
Radius Health (RDUS) Announces License And Development Agreement For Abaloparatide-SC With Teijin Limited In Japan 7/13/2017 10:25:26 AM
Radius Health (RDUS) To Announce Second Quarter 2017 Financial Results, Host Conference Call And Live Webcast On August 3, 2017 7/7/2017 10:44:37 AM
Radius Health (RDUS) Presents Positive Data From A Fully Enrolled Ongoing Phase I Study For Investigational Drug Elacestrant (RAD1901) At The 2017 ASCO 6/5/2017 12:51:32 PM
Radius Health (RDUS)'s Osteoporosis Drug Meets All Primary and Secondary Endpoints in Phase III Test 5/25/2017 8:04:52 AM
Radius Health (RDUS) Announces New Employment Inducement Grant 5/16/2017 10:54:00 AM
12345678910...
//-->